| Year |
Citation |
Score |
| 2022 |
Guo Y, Wang L, Qi Z, Liu Y, Tian K, Qiang H, Wang P, Zhou G, Zhang X, Xu S. A novel strategy for orthogonal genetic regulation on different RNA targeted loci simultaneously. Rna Biology. 19: 1172-1178. PMID 36350790 DOI: 10.1080/15476286.2022.2141507 |
0.354 |
|
| 2005 |
Guo Y, Jamison DC. The distribution of SNPs in human gene regulatory regions. Bmc Genomics. 6: 140. PMID 16209714 DOI: 10.1186/1471-2164-6-140 |
0.328 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2008 |
Zhuo CS, Zhuo XF, Guo YJ, Wang CQ. RHD gene polymorphism of RhD negative individuals in population of Fujian province Zhongguo Shi Yan Xue Ye Xue Za Zhi / Zhongguo Bing Li Sheng Li Xue Hui = Journal of Experimental Hematology / Chinese Association of Pathophysiology. 16: 435-438. PMID 18426681 |
0.239 |
|
| 2016 |
Dutta B, Azhir A, Merino LH, Guo Y, Revanur S, Madhamshettiwar PB, Germain RN, Smith JA, Simpson KJ, Martin SE, Beuhler E, Fraser ID. An interactive web-based application for Comprehensive Analysis of RNAi-screen Data. Nature Communications. 7: 10578. PMID 26902267 DOI: 10.1038/Ncomms10578 |
0.21 |
|
| 2015 |
Liu K, Guo L, Guo Y, Zhou B, Li T, Yang H, Yin R, Xi T. AEG-1 3'-untranslated region functions as a ceRNA in inducing epithelial-mesenchymal transition of human non-small cell lung cancer by regulating miR-30a activity. European Journal of Cell Biology. 94: 22-31. PMID 25484183 DOI: 10.1016/j.ejcb.2014.10.006 |
0.201 |
|
| 2022 |
Liu CC, Guo Y, Vrindten KL, Lau WW, Sparks R, Tsang JS. OMiCC: An expanded and enhanced platform for meta-analysis of public gene expression data. Star Protocols. 3: 101474. PMID 35880119 DOI: 10.1016/j.xpro.2022.101474 |
0.195 |
|
| 2010 |
Barenboim M, Zoltick BJ, Guo Y, Weinberger DR. MicroSNiPer: a web tool for prediction of SNP effects on putative microRNA targets. Human Mutation. 31: 1223-32. PMID 20809528 DOI: 10.1002/Humu.21349 |
0.193 |
|
| 2020 |
Tian K, Guo Y, Zou B, Wang L, Zhang Y, Qi Z, Zhou J, Wang X, Zhou G, Wei L, Xu S. DNA and RNA editing without sequence limitation using the flap endonuclease 1 guided by hairpin DNA probes. Nucleic Acids Research. PMID 33051689 DOI: 10.1093/nar/gkaa843 |
0.192 |
|
| 2012 |
Tu J, Xing Y, Guo Y, Tang F, Guo L, Xi T. TanshinoneIIA ameliorates inflammatory microenvironment of colon cancer cells via repression of microRNA-155. International Immunopharmacology. 14: 353-61. PMID 22982040 DOI: 10.1016/j.intimp.2012.08.015 |
0.174 |
|
| 2007 |
Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC, Lempicki RA. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Research. 35: W169-75. PMID 17576678 DOI: 10.1093/Nar/Gkm415 |
0.16 |
|
| 2023 |
Guo Y, Tian J, Guo Y, Wang C, Chen C, Cai S, Yu W, Sun B, Yan J, Li Z, Fan J, Qi Q, Zhang D, Jin W, Hua Z, et al. Oncogenic KRAS effector USP13 promotes metastasis in non-small cell lung cancer through deubiquitinating β-catenin. Cell Reports. 42: 113511. PMID 38043062 DOI: 10.1016/j.celrep.2023.113511 |
0.145 |
|
| 2009 |
Guo Y, Ribeiro JM, Anderson JM, Bour S. dCAS: a desktop application for cDNA sequence annotation. Bioinformatics (Oxford, England). 25: 1195-6. PMID 19318425 DOI: 10.1093/bioinformatics/btp129 |
0.139 |
|
| 2020 |
Lin L, Gong H, Li R, Huang J, Cai M, Lan T, Huang W, Guo Y, Zhou Z, An Y, Chen Z, Liang L, Wang Y, Shuai X, Zhu K. Nanodrug with ROS and pH Dual-Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 7: 1903138. PMID 32274310 DOI: 10.1002/advs.201903138 |
0.137 |
|
| 2023 |
Liu M, Xie L, Zhang Y, Chen J, Zhang X, Chen Y, Huang W, Cai M, Liang L, Lai M, Huang J, Guo Y, Lin L, Zhu K. Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases. Cell Death & Disease. 14: 25. PMID 36639658 DOI: 10.1038/s41419-023-05550-4 |
0.135 |
|
| 2016 |
Dutta B, Azhir A, Merino LH, Guo Y, Revanur S, Madhamshettiwar PB, Germain RN, Smith JA, Simpson KJ, Martin SE, Buehler E, Fraser ID. Corrigendum: An interactive web-based application for Comprehensive Analysis of RNAi-screen Data. Nature Communications. 7: 11214. PMID 26997126 DOI: 10.1038/Ncomms11214 |
0.134 |
|
| 2023 |
Qing Y, Guo Y, Zhao Q, Hu P, Li H, Yu X, Zhu M, Wang H, Wang Z, Xu J, Guo Q, Hui H. Targeting lysosomal HSP70 induces acid sphingomyelinase-mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies. Clinical and Translational Medicine. 13: e1229. PMID 36959764 DOI: 10.1002/ctm2.1229 |
0.131 |
|
| 2021 |
Yao J, Wang J, Xu Y, Guo Q, Sun Y, Liu J, Li S, Guo Y, Wei L. CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Autophagy. 1-19. PMID 34890308 DOI: 10.1080/15548627.2021.2007027 |
0.124 |
|
| 2020 |
Ma J, Zhi Q, Gong L, Shen Y, Sun D, Guo Y, Zhang L, Xia Z. A universal descriptor based on p-orbitals for the catalytic activity of multi-doped carbon bifunctional catalysts for oxygen reduction and evolution. Nanoscale. PMID 32945308 DOI: 10.1039/D0Nr03521A |
0.123 |
|
| 2007 |
Sherman BT, Huang da W, Tan Q, Guo Y, Bour S, Liu D, Stephens R, Baseler MW, Lane HC, Lempicki RA. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. Bmc Bioinformatics. 8: 426. PMID 17980028 DOI: 10.1186/1471-2105-8-426 |
0.122 |
|
| 2019 |
Guo Y, Bai M, Lin L, Huang J, An Y, Liang L, Liu Y, Huang W. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 118: 109272. PMID 31376657 DOI: 10.1016/j.biopha.2019.109272 |
0.122 |
|
| 2023 |
Wang X, Zhang Q, Zhou J, Xiao Z, Liu J, Deng S, Hong X, Huang W, Cai M, Guo Y, Huang J, Wang Y, Lin L, Zhu K. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma. Journal For Immunotherapy of Cancer. 11. PMID 36813307 DOI: 10.1136/jitc-2022-006493 |
0.119 |
|
| 2021 |
Chen Y, Bei J, Liu M, Huang J, Xie L, Huang W, Cai M, Guo Y, Lin L, Zhu K. Sublethal heat stress-induced O-GlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation. Cancer Letters. PMID 34126196 DOI: 10.1016/j.canlet.2021.06.001 |
0.119 |
|
| 2020 |
Zhu Y, Guo Y, Liu M, Wei L, Wang X. An oroxylin A-loaded aggregation-induced emission active polymeric system greatly increased the antitumor efficacy against squamous cell carcinoma. Journal of Materials Chemistry. B. PMID 32100790 DOI: 10.1039/C9Tb01818B |
0.108 |
|
| 2015 |
Dai Q, Yin Q, Wei L, Zhou Y, Qiao C, Guo Y, Wang X, Ma S, Lu N. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells. Molecular Carcinogenesis. PMID 26259145 DOI: 10.1002/Mc.22369 |
0.108 |
|
| 2018 |
Meng XC, Chen BH, Huang JJ, Huang WS, Cai MY, Zhou JW, Guo YJ, Zhu KS. Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib. World Journal of Gastroenterology. 24: 484-493. PMID 29398869 DOI: 10.3748/wjg.v24.i4.484 |
0.107 |
|
| 2023 |
Zhang X, Zhao X, Shao Z, Wen X, Lu L, Li M, Liu J, Li Y, Zhang S, Guo Y, Liu X, Yue L, Li J, Liu J, Zhu Y, et al. The potential of electroencephalography coherence to predict the outcome of repetitive transcranial magnetic stimulation in insomnia disorder. Journal of Psychiatric Research. 160: 56-63. PMID 36774831 DOI: 10.1016/j.jpsychires.2023.02.005 |
0.103 |
|
| 2023 |
Chen Y, Bei J, Chen M, Cai W, Zhou Z, Cai M, Huang W, Lin L, Guo Y, Liu M, Huang X, Xiao Z, Xu Z, Zhu K. Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy Against Post-Ablative Hepatocellular Carcinoma Recurrence. Advanced Healthcare Materials. e2303031. PMID 37848188 DOI: 10.1002/adhm.202303031 |
0.101 |
|
| 2022 |
Liu M, Huang W, Guo Y, Zhou Y, Zhi C, Chen J, Li J, He J, Lian H, Zhou J, Ye X, Hu Y, Hu H, Liu Z, Huang J, et al. CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo. Journal of Leukocyte Biology. PMID 35088475 DOI: 10.1002/JLB.5MA0122-467R |
0.099 |
|
| 2023 |
Liu J, Guo Y, Zhang R, Xu Y, Luo C, Wang R, Xu S, Wei L. Inhibition of TRPV4 remodels single cell polarity and suppresses the metastasis of hepatocellular carcinoma. Cell Death & Disease. 14: 379. PMID 37369706 DOI: 10.1038/s41419-023-05903-z |
0.094 |
|
| 2013 |
Guo YJ, Huang WS, Zhou B, Chen JW, Cai MY, Qian JS, Huang MS, Shan H, Zhu KS. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations]. Zhonghua Yi Xue Za Zhi. 93: 2627-30. PMID 24360041 |
0.089 |
|
| 2021 |
Zhou Y, Guo Y, Zhu Y, Sun Y, Li W, Li Z, Wei L. Dual PPARγ/ɑ Agonist Oroxyloside Suppresses Cell Cycle Progression by Glycolipid Metabolism Switch-Mediated Increase of Reactive Oxygen Species Levels. Free Radical Biology & Medicine. PMID 33713839 DOI: 10.1016/j.freeradbiomed.2021.02.032 |
0.088 |
|
| 2023 |
Xie L, Liu M, Cai M, Huang W, Guo Y, Liang L, Cai W, Liu J, Liang W, Tan Y, Lai M, Lin L, Zhu K. Regorafenib enhances anti-tumor efficacy of immune checkpoint inhibitor by regulating IFN-γ/NSDHL/SREBP1/TGF-β1 axis in hepatocellular carcinoma. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 159: 114254. PMID 36669362 DOI: 10.1016/j.biopha.2023.114254 |
0.081 |
|
| 2016 |
Shah N, Guo Y, Wendelsdorf KV, Lu Y, Sparks R, Tsang JS. A crowdsourcing approach for reusing and meta-analyzing gene expression data. Nature Biotechnology. PMID 27323300 DOI: 10.1038/Nbt.3603 |
0.075 |
|
| 2022 |
Sun Y, Guo W, Guo Y, Lin Z, Wang D, Guo Q, Zhou Y. Apoptosis induction in human prostate cancer cells related to the fatty acid metabolism by wogonin-mediated regulation of the AKT-SREBP1-FASN signaling network. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 169: 113450. PMID 36208653 DOI: 10.1016/j.fct.2022.113450 |
0.075 |
|
| 2021 |
Guo Y, Yang L, Guo W, Wei L, Zhou Y. FV-429 enhances the efficacy of paclitaxel in NSCLC by reprogramming HIF-1α-modulated FattyAcid metabolism. Chemico-Biological Interactions. 109702. PMID 34648812 DOI: 10.1016/j.cbi.2021.109702 |
0.071 |
|
| 2021 |
Cao B, Liu M, Huang J, Zhou J, Li J, Lian H, Huang W, Guo Y, Yang S, Lin L, Cai M, Zhi C, Wu J, Liang L, Hu Y, et al. Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer. International Journal of Biological Sciences. 17: 3850-3861. PMID 34671203 DOI: 10.7150/ijbs.64630 |
0.07 |
|
| 2019 |
Guo Y, Wei L, Zhou Y, Lu N, Tang X, Li Z, Wang X. Flavonoid GL-V9 induces apoptosis and inhibits glycolysis of breast cancer via disrupting GSK-3β-modulated mitochondrial binding of HKII. Free Radical Biology & Medicine. PMID 31669347 DOI: 10.1016/J.Freeradbiomed.2019.10.413 |
0.069 |
|
| 2022 |
Guo Y, Ghobeira R, Aliakbarshirazi S, Morent R, De Geyter N. Polylactic Acid/Polyaniline Nanofibers Subjected to Pre- and Post-Electrospinning Plasma Treatments for Refined Scaffold-Based Nerve Tissue Engineering Applications. Polymers. 15. PMID 36616422 DOI: 10.3390/polym15010072 |
0.065 |
|
| 2018 |
Lin L, Li R, Cai M, Huang J, Huang W, Guo Y, Yang L, Yang G, Lan T, Zhu K. Andrographolide Ameliorates Liver Fibrosis in Mice: Involvement of TLR4/NF-B and TGF-1/Smad2 Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2018: 7808656. PMID 29743985 DOI: 10.1155/2018/7808656 |
0.064 |
|
| 2023 |
Guo Y, Luo C, Sun Y, Guo W, Zhang R, Zhang X, Ke X, Wei L. Inhibition of mitochondrial fusion via SIRT1/PDK2/PARL axis breaks mitochondrial metabolic plasticity and sensitizes cancer cells to glucose restriction therapy. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 166: 115342. PMID 37633053 DOI: 10.1016/j.biopha.2023.115342 |
0.063 |
|
| 2023 |
Guo Y, Zhao X, Liu X, Liu J, Li Y, Yue L, Yuan F, Zhu Y, Sheng X, Yu D, Yuan K. Electroencephalography microstates as novel functional biomarkers for insomnia disorder. General Psychiatry. 36: e101171. PMID 38143715 DOI: 10.1136/gpsych-2023-101171 |
0.062 |
|
| 2024 |
Shao Z, Guo Y, Yue L, Liu X, Liu J, Zhao X, Sheng X, Yu D, Zhu Y, Yuan K. Comparisons of transcranial alternating current stimulation and repetitive transcranial magnetic stimulation treatment therapy for insomnia: a pilot study. General Psychiatry. 37: e101184. PMID 38390243 DOI: 10.1136/gpsych-2023-101184 |
0.059 |
|
| 2019 |
Guo Y, Zhao Y, Zhou Y, Tang X, Li Z, Wang X. LZ-101, a novel derivative of danofloxacin, induces mitochondrial apoptosis by stabilizing FOXO3a via blocking autophagy flux in NSCLC cells. Cell Death & Disease. 10: 484. PMID 31217472 DOI: 10.1038/S41419-019-1714-Y |
0.058 |
|
| 2018 |
Xu Q, Cai W, Zhang M, Su R, Ye Y, Li Y, Zhang L, Guo Y, Yu Z, Li S, Lin X, Chen Y, Luo Y, Street J, Xu M. Photoluminescence mechanism and applications of Zn-doped carbon dots. Rsc Advances. 8: 17254-17262. PMID 35539221 DOI: 10.1039/c8ra02756k |
0.051 |
|
| 2023 |
Zhu MY, Wang T, Wang HD, Wang HZ, Chen HY, Zhang S, Guo YJ, Li H, Hui H. LW-213 induces immunogenic tumor cell death via ER stress mediated by lysosomal TRPML1. Cancer Letters. 577: 216435. PMID 37806516 DOI: 10.1016/j.canlet.2023.216435 |
0.047 |
|
| 2019 |
Li J, Hu R, Guo Y, Chen S, Xie X, Qin JG, Ma Z, Zhu C, Pei S. Bioturbation of peanut worms Sipunculus nudus on the composition of prokaryotic communities in a tidal flat as revealed by 16S rRNA gene sequences. Microbiologyopen. e802. PMID 30734523 DOI: 10.1002/mbo3.802 |
0.047 |
|
| 2016 |
Guo Y, Zhang Y, Huang J, Chen X, Huang W, Shan H, Zhu K. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria. Journal of Vascular and Interventional Radiology : Jvir. PMID 26922006 DOI: 10.1016/j.jvir.2016.01.002 |
0.046 |
|
| 2018 |
Zhu K, Huang J, Lai L, Huang W, Cai M, Zhou J, Guo Y, Chen J. Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation. Radiology. 172028. PMID 29688153 DOI: 10.1148/radiol.2018172028 |
0.045 |
|
| 2019 |
Su R, Guan Q, Cai W, Yang W, Xu Q, Guo Y, Zhang L, Fei L, Xu M. Multi-color carbon dots for white light-emitting diodes. Rsc Advances. 9: 9700-9708. PMID 35520699 DOI: 10.1039/c8ra09868a |
0.044 |
|
| 2021 |
Huang J, Huang W, Zhan M, Guo Y, Liang L, Cai M, Lin L, He M, Lian H, Lu L, Zhu K. Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 8: 1445-1458. PMID 34858889 DOI: 10.2147/JHC.S339379 |
0.041 |
|
| 2017 |
Zhang B, Guo Y, Wu K, Shan H. Intrahepatic biloma following transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence, imaging features and management. Molecular and Clinical Oncology. 6: 937-943. PMID 28588794 DOI: 10.3892/mco.2017.1235 |
0.04 |
|
| 2021 |
Huang J, Huang W, Guo Y, Cai M, Zhou J, Lin L, Zhu K. Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma. Frontiers in Oncology. 11: 638428. PMID 34123790 DOI: 10.3389/fonc.2021.638428 |
0.04 |
|
| 2021 |
Huang JJ, Cai MY, Huang WS, Guo YJ, Zhou JW, Liang LC, Lin LT, Zhou ZM, Lian H, He MJ, Zhu KS. Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study. Chinese Medical Journal. PMID 34507316 DOI: 10.1097/CM9.0000000000001537 |
0.039 |
|
| 2022 |
Cai J, Liu M, Zhang Q, Shao Z, Zhou J, Guo Y, Liu J, Wang X, Zhang B, Li X. Renal Cancer Detection: Fusing Deep and Texture Features from Histopathology Images. Biomed Research International. 2022: 9821773. PMID 35386304 DOI: 10.1155/2022/9821773 |
0.038 |
|
| 2022 |
Cai M, Huang W, Huang J, Shi W, Guo Y, Liang L, Zhou J, Lin L, Cao B, Chen Y, Zhou J, Zhu K. Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study. Frontiers in Immunology. 13: 848387. PMID 35300325 DOI: 10.3389/fimmu.2022.848387 |
0.038 |
|
| 2022 |
Huang J, Guo Y, Huang W, Hong X, Quan Y, Lin L, Zhou J, Liang L, Zhang Y, Zhou J, Cai M, Zhu K. Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study. Journal of Hepatocellular Carcinoma. 9: 157-170. PMID 35300208 DOI: 10.2147/JHC.S353956 |
0.037 |
|
| 2023 |
Guo Y, Wu J, Liang L, Zhu K, Zhou J, Lin L, Chen Y, Cao B, He M, Lian H, Huang W, Cai M. Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study. Cancer Imaging : the Official Publication of the International Cancer Imaging Society. 23: 91. PMID 37749616 DOI: 10.1186/s40644-023-00604-4 |
0.033 |
|
| 2023 |
Bei J, Chen Y, Zhang Q, Wang X, Lin L, Huang J, Huang W, Cai M, Cai W, Guo Y, Zhu K. HBV suppresses macrophage immune responses by impairing the TCA cycle through the induction of CS/PDHC hyperacetylation. Hepatology Communications. 7. PMID 37820280 DOI: 10.1097/HC9.0000000000000294 |
0.033 |
|
| 2024 |
Wang R, Min Q, Guo Y, Zhou Y, Zhang X, Wang D, Gao Y, Wei L. GL-V9 inhibits the activation of AR-AKT-HK2 signaling networks and induces prostate cancer cell apoptosis through mitochondria-mediated mechanism. Iscience. 27: 109246. PMID 38439974 DOI: 10.1016/j.isci.2024.109246 |
0.033 |
|
| 2013 |
Chen JW, Pang PF, Meng XC, Zhou B, Huang WS, Guo YJ, Zhu KS, Shan H. [Clinical observation of transcatheter arterial chemoembolization plus sorafenib in the treatment of advanced hepatocellular carcinoma with different types of portal vein tumor thrombosis]. Zhonghua Yi Xue Za Zhi. 93: 663-7. PMID 23751743 |
0.029 |
|
| 2013 |
Cai M, Zhu K, Huang W, Meng X, He K, Zhou B, Guo Y, Chen J, Shan H. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up. Journal of Vascular and Interventional Radiology : Jvir. 24: 1808-16. PMID 24099787 DOI: 10.1016/j.jvir.2013.08.018 |
0.029 |
|
| 2024 |
Cai M, Huang W, Liang W, Guo Y, Liang L, Lin L, Xie L, Zhou J, Chen Y, Cao B, Wu J, Zhu K. Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 38291865 DOI: 10.1111/liv.15831 |
0.029 |
|
| 2019 |
Gao F, Guo Y, Fan X, Hu M, Li S, Zhai Q, Jiang Y, Wang X. Enhancing the catalytic performance of chloroperoxidase by co-immobilization with glucose oxidase on magnetic graphene oxide Biochemical Engineering Journal. 143: 101-109. DOI: 10.1016/J.BEJ.2018.12.013 |
0.026 |
|
| 2017 |
Zhang B, Wu KT, Guo YJ, Li L, Lai HY. Safety and feasibility of temporary superior vena cava filter combined with balloon dilatation and catheter directed thrombolysis for catheter related thrombosis. Annals of Vascular Surgery. PMID 28893705 DOI: 10.1016/j.avsg.2017.08.035 |
0.025 |
|
| 2018 |
Liu Y, Huang W, He M, Lian H, Guo Y, Huang J, Zhou J, Zhu K. Efficacy and safety of CalliSpheres® drug-eluting beads transarterial chemoembolization in Barcelona Clinic Liver Cancer stage C patients. Oncology Research. PMID 30005719 DOI: 10.3727/096504018X15313896322888 |
0.021 |
|
| 2023 |
Guo Y, Zhao X, Zhang X, Li M, Liu X, Lu L, Liu J, Li Y, Zhang S, Yue L, Li J, Liu J, Zhu Y, Zhu Y, Sheng X, et al. Effects on resting-state EEG phase-amplitude coupling in insomnia disorder patients following 1 Hz left dorsolateral prefrontal cortex rTMS. Human Brain Mapping. PMID 36919444 DOI: 10.1002/hbm.26264 |
0.019 |
|
| Hide low-probability matches. |